Promoter Hypermethylation Analysis of the Tumor Suppressor Genes RASSF1A and RASSF2A in Iranian Endometrial Carcinoma Patients
Journal Title: International Journal of Cancer Management - Year 2017, Vol 10, Issue 4
Abstract
Introduction The endometrial cancer (EC) is the seventh most common malignancies worldwide among females with good prognosis in early stages of the disease. The CpG Island in the promoter region of tumor-suppressor genes are frequently methylated in various types of human cancers. In the present study, we investigated the methylation pattern in promoter region of <i>RASSF1A</i> and RASSF2A genes in Endometrial cancer patients in Iranian women to identify correlations among promoter hypermethylation, disease risk and clinicopathological parameters. Methods 28 patients and 22 healthy controls were studied. Isolation of genomic DNA from FFPE and peripheral blood was performed and Methylation-Specific PCR (MSP) was applied for analysis of the promoter CpG methylation status of <i>RASSF1A</i> and RASSF2A genes in the studied population. Results A significant difference was found among the study groups and the presence of promoter CpG hypermethylation status in the <i>RASSF1A</i> (P = 0.0321) and <i>RASSF2A </i>(P = 0.0003) genes. <i>RASSF1A</i>, and <i>RASSF2A</i> gene promoter methylations were present in 53.57% and 42.85% of EC samples when compared to those in the controls with 31.81% and 9.09% respectively. Furthermore, methylation status between tissue and blood samples of <i>RASSF1A</i>, and RASSF2A genes was not significant (P = 0.49 and 0.09 respectively). Our results indicated a corollation between ages, menosososal state and tumor grade with <i>RASSF1A</i>, and <i>RASSF2A</i> promoter methylation. Conclusions In our study, Hypermethylation of both <i>RASSF1A</i> and <i>RASSF2A</i> genes are important events in carcinogenesis of endometrial cancer. Epigenetic alternations may have diagnostic value for early diagnosis and better clicinal management of susceptibility to endometrial malignancies.
Authors and Affiliations
Neda Jabbara, Golnaz Asaadi Tehrani, Fatemeh Lalooha, Seyed Amir Farzam, Khadijeh Elmizadeh
Keywords
Related Articles
- EP ID EP237357
- DOI 10.5812/ijcm.8629
- Views 68
- Downloads 0
Clinicopathology Illustration Treatment Options and Survival in the Patients with Testicular Germ Cell Tumors in Kermanshah Province, Iran
Background: Testicular germ cell tumors (TGCTs) account for only 1% - 2% of all male neoplasma. Objectives: The aim of this study is to evaluate clinicopathological features, treatment options and overall survival (OS) i...
Association between VDR Gene Polymorphisms (<i>rs 1544410</i>, <i>rs 7975232</i>, <i>rs 2228570</i>, <i>rs 731236</i> and <i>rs 11568820</i>) and Susceptibility to Breast Cancer in a Sample of Southeastern Iranian Population
Background Vitamin D receptor (VDR) is a key nuclear receptor that is associated with the risk and progression of breast cancer (BC). Objectives The present study investigated the...
A Dynamic Model for Predicting Prostate Cancer in Iranian Men Based on a Perceptron Neural Network
Objectives To test a novel neural network prediction model for prostate cancer based on age, rectal examination, prostate specific antigen (PSA) and prostate volume. Methods 572 m...
Current Status of the Fetography: Preventing of the Future Radiation Induced Cancer
Background: Fetography has named the radiography of the fetus in utero. Due to the potential risk of radiation-induced cancers and other malignant effects, this procedure has avoided and has completely replaced by ultras...
Sensitization of Radio-Resistant Lung Cancer Cells with a B Subunit of Bacterial Cytolethal Distending Toxin from <i>Aggregatibacter actinomycetemcomitans</i>
Background Combination cancer therapy is a promising strategy which employs multiple therapeutic agents with different mechanisms of action along with minimal intolerable side eff...